v3.26.1
Condensed Consolidated Statements of Operations and Comprehensive Income (Loss) (Unaudited) - USD ($)
shares in Thousands, $ in Thousands
3 Months Ended
Mar. 31, 2026
Mar. 31, 2025
Operating expenses:    
Research and development $ 84,570 $ 95,589
General and administrative 24,609 27,986
Total operating expenses 109,179 123,575
Loss from operations (109,179) (123,575)
Other income (expense):    
Interest expense (478) (528)
Interest income 8,890 9,769
Other income (expense) (25) 80
Loss before income taxes (100,792) (114,254)
Income tax provision (7) (169)
Net loss (100,799) (114,423)
Other comprehensive income (loss):    
Unrealized loss on marketable securities (1,028) (328)
Total comprehensive loss $ (101,827) $ (114,751)
Net loss per share - Basic $ (0.16) $ (0.21)
Net loss per share - Diluted $ (0.16) $ (0.21)
Weighted-average common shares outstanding - Basic 611,013 548,006
Weighted-average common shares outstanding - Diluted 611,013 548,006